Amarin Corp Plc (AMRN)

[KCSVEN]

I know people seem to be into that, but you still have generics in 2029. I don't believe the extra indications, if any of them came to fruition, which is still years away, would prevent generics from taking over in 2029 assuming they can make Vascepa.

Of course if Vascepa is proven to delay Alzheimers and slow cancer growth the demand would be so high supply probably becomes the biggest issue, so we are back to who controls the supply. New indications, IMO will not stop generics from being prescribed for those indications in 2029 so trying to look beyond 2029.

Yes, look to expand Vascepa use, of course the company itself is not doing ANY trials right now, all trials are third party and years away and look to buy a pipeline with right deal, but i think the best play revolves around supply. But just theorizing not sure.